Turn Therapeutics Inc. (TTRX) stock
TTRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$8.55+0.00 (0.00%)
Close on Nov 17, 2026Market cap $254.69MP/E –Yield –
Turn Therapeutics r&d expenses
Research and development expenses are spending on new products and technology.
Turn Therapeutics's R&D Expenses for the twelve months ending Sep 30, 2026 was $1.22M, up 409.4% year over year. For fiscal 2025 it was $265.57K, up 8.0% from the year before.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $265.57K | +8.0% |
| FY2024 | Dec 31, 2024 | $245.96K | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $605.20K | +281.3% |
| Q2 FY2026 | Jun 30, 2026 | $475.06K | +657.9% |
| Q1 FY2026 | Mar 31, 2026 | $109.43K | +1081.9% |
| Q4 FY2025 | Dec 31, 2025 | $34.93K | +257.7% |
| Q3 FY2025 | Sep 30, 2025 | $158.70K | +3.5% |
| Q2 FY2025 | Jun 30, 2025 | $62.68K | – |
| Q1 FY2025 | Mar 31, 2025 | $9.26K | – |
| Q4 FY2024 | Dec 31, 2024 | $9.77K | – |
| Q3 FY2024 | Sep 30, 2024 | $153.28K | – |
See a number that looks wrong?